行情

BIO-B

BIO-B

BIO RAD LABORATO
NYSE

实时行情|Nasdaq Last Sale

351.32
+0.66
+0.19%
已收盘, 16:00 04/01 EDT
开盘
351.98
昨收
332.00
最高
351.98
最低
351.98
成交量
19
成交额
--
52周最高
403.83
52周最低
287.85
市值
105.13亿
市盈率(TTM)
6.04
分时
5日
1月
3月
1年
5年

BIO-B 新闻

更多
  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article · 03/24 18:33
  • Bio-Rad partners with laboratories for COVID-19 testing
  • Seeking Alpha - Article · 03/19 11:29
  • Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 02/14 02:04
  • IPO Update: Beam Therapeutics Proposes IPO Terms
  • Seeking Alpha - Article · 01/27 20:15

所属板块

医疗设备、用品及经销
-4.79%
医疗设备和用品
-4.98%

热门股票

代码
价格
涨跌幅

BIO-B 简况

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
展开

微牛提供Bio-Rad Laboratories, Inc.(NYSE-BIO B)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BIO B股票新闻,以帮助您做出投资决策。